Update on the Phase 4 Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 220.77 +2.65 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $218.12 | 52 Week High | $333.65 | |||
| Open | $218.93 | 52 Week Low | $223.02 | |||
| Day High | $222.85 | P/E | 28.27 | |||
| Day Low | $218.00 | EPS | $7.81 | |||
| Volume | 496,696 | |||||
